Skip to content

Clinical trials

Terminated Diabetes Mellitus, Type 1 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Status: Terminated Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20063
20071
20092
20122
20131
20143
20171
20181
20192
20211
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Cliniques de Montreal2
McGill University2
Novo Nordisk A/S2
University of Alberta2
University of British Columbia2
CRISPR Therapeutics AG1
Centre hospitalier de l'Université de Montréal (CHUM)1
Eli Lilly and Company1
Exsulin Corporation1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 123
Diabetes Mellitus5
Diabetes Mellitus, Type 24
Hypoglycemia3
Asthma1
Autoimmune Diseases1
Diabetic Retinopathy1
Endocrine System Diseases1
Eye Diseases1
Glucose Metabolism Disorders1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.